TY - JOUR
T1 - Emollient foam in topical drug delivery
AU - Tamarkin, Dov
AU - Friedman, Doron
AU - Shemer, Avner
PY - 2006/11
Y1 - 2006/11
N2 - Foams offer an innovative and more convenient means of topical drug delivery. The successful introduction of hydroalcoholic foams paved the way for the development of a new generation of foam products that provide skin barrier build-up and hydration. Such foams, designated as emollient foams consist of oil-in-water or water-in-oil emulsions with necessary excipients, such as non-ionic surfactants, gelling agents and foam adjuvants. Emollient foams can carry a broad variety of topical drugs, including water-soluble, oil-soluble and suspended active agents. This paper reviews emollient foam compositions and their physicochemical properties. It further accounts for the usability and functional advantages of emollient foam as a vehicle of topical drugs, including: i) improved usability, which affects treatment, compliance and, consequently, improves therapeutic results; ii) safety; iii) controllable drug delivery; iv) skin barrier build-up and hydration; and v) enhanced clinical efficacy.
AB - Foams offer an innovative and more convenient means of topical drug delivery. The successful introduction of hydroalcoholic foams paved the way for the development of a new generation of foam products that provide skin barrier build-up and hydration. Such foams, designated as emollient foams consist of oil-in-water or water-in-oil emulsions with necessary excipients, such as non-ionic surfactants, gelling agents and foam adjuvants. Emollient foams can carry a broad variety of topical drugs, including water-soluble, oil-soluble and suspended active agents. This paper reviews emollient foam compositions and their physicochemical properties. It further accounts for the usability and functional advantages of emollient foam as a vehicle of topical drugs, including: i) improved usability, which affects treatment, compliance and, consequently, improves therapeutic results; ii) safety; iii) controllable drug delivery; iv) skin barrier build-up and hydration; and v) enhanced clinical efficacy.
KW - Emollient foam
KW - Skin penetration
KW - Topical therapy
KW - Usability
UR - http://www.scopus.com/inward/record.url?scp=33751225645&partnerID=8YFLogxK
U2 - 10.1517/17425247.3.6.799
DO - 10.1517/17425247.3.6.799
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 17076601
AN - SCOPUS:33751225645
SN - 1742-5247
VL - 3
SP - 799
EP - 807
JO - Expert Opinion on Drug Delivery
JF - Expert Opinion on Drug Delivery
IS - 6
ER -